The University of Chicago Header Logo

Connection

Thinle Chodon to Melanoma, Experimental

Back to Details
This is a "connection" page, showing publications Thinle Chodon has written about Melanoma, Experimental.
Thinle Chodon
Connection Strength
0.026
Melanoma, Experimental
  1. BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy. Cancer Res. 2012 Aug 15; 72(16):3928-37.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.